Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
OPIANT PHARMACEUTICALS, INC. | Chief Development Officer | Common Stock | 0 | $20.00 | Mar 2, 2023 | Direct | |
OPIANT PHARMACEUTICALS, INC. | Chief Development Officer | Common Stock | 0 | $20.00 | Mar 2, 2023 | Indirect | |
OPIANT PHARMACEUTICALS, INC. | Chief Development Officer | Stock Option (right to buy) | 0 | $10.00 | Mar 2, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OPNT | OPIANT PHARMACEUTICALS, INC. | Mar 2, 2023 | 8 | -$609K | 4 | Mar 3, 2023 | Chief Development Officer |
OPNT | OPIANT PHARMACEUTICALS, INC. | Jan 27, 2023 | 1 | -$12.4K | 4 | Jan 31, 2023 | Chief Development Officer |
OPNT | OPIANT PHARMACEUTICALS, INC. | Jan 9, 2023 | 1 | -$9.47K | 4 | Jan 9, 2023 | Chief Development Officer |
OPNT | OPIANT PHARMACEUTICALS, INC. | Jan 5, 2023 | 1 | -$36.5K | 4 | Jan 5, 2023 | Chief Development Officer |
OPNT | OPIANT PHARMACEUTICALS, INC. | Jun 27, 2022 | 1 | $0 | 4 | Jun 29, 2022 | Chief Development Officer |
OPNT | OPIANT PHARMACEUTICALS, INC. | Jan 4, 2022 | 1 | $0 | 4 | Jan 5, 2022 | Chief Development Officer |